Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
University of California, San Diego
Memorial Sloan Kettering Cancer Center
University of Texas Southwestern Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
University of Zurich
Roswell Park Cancer Institute
University of Chicago
Fox Chase Cancer Center
Roswell Park Cancer Institute
Groupe Oncologie Radiotherapie Tete et Cou